Top Health-care stocks:
Health-care shares were mainly higher in pre-market trade on Monday.
In health-care stocks news, Biohaven Pharmaceutical ( BHVN ) said Monday its Q2 net loss was $1.78 per share, wider than its $0.55 per share loss a year ago. Four analysts polled by Capital IQ had expected an adjusted loss of $0.62 per share, but this may not be comparable.
Shares in the company were unchanged at $24.40 in early trade. The stock has traded between $17 and $29.50 over the past 52 weeks.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.